ZFP36 and psoriasis: Eventually, in the absence of mutations or genomic loss events that could explain TTP downregulation during the pathogenesis of psoriasis, we provide evidence supporting the idea that ZFP36 downregulation in psoriasis might depend on epigenetic mechanisms.